Discover Top Posts Tagged with #novaseq

Ilumina to report Q4 earnings

Gene-sequencing firm Illumina (NASDAQ: ILMN) is scheduled to report its Q4 results today after the bell. The company is expected to report solid results in the fourth quarter continuing the trend from the last quarter. NovaSeq sales will be closely tracked by the street.

Analysts are expecting Illumina to earn $1.36 per share on $863.54 million revenues for the fourth quarter. For the same period…